Pulmonx Corp
NASDAQ:LUNG
| Market Cap (Intraday) | NA |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $7.81 |
| 50-Day MA | $9.87 |
| 200-Day MA | $10.98 |
Pulmonx Corp Stock, NASDAQ:LUNG
700 Chesapeake Drive, Redwood City, California 94063
United States of America
Phone: +1.650.364.0400
Number of Employees: 279
Description
Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.